12:09 PM EST - Helix BioPharma Corp. : announced financial results for the quarter ended April 30, 2011. The Company recorded a loss of $2,939,000 for a loss per common share of $0.05. In the comparative three-month period ended April 30, 2010, the Company recorded a loss of $4,200,000 for a loss per common share of $0.07 and $0.19, respectively. Revenues totaled $1,089,000 for the three-month period ended April 30, 2011 and represent a decrease of $25,000 (2.2%) when compared to the three-month period ended April 30, 2010. Helix BioPharma Corp.
shares T.HBP are trading even at $3.04.
